000			04123nam a22004095c 4500
999			_c112494 _d112494 _x1
001			112494
003			ES-MaUEC
005			20230102113531.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			190107s2019 si a s |||| 0|eng d
020			_a9789811329319
024	7		_a10.1007/978-981-13-2931-9 _2doi
040			_bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC280.M6 _b2019 EB
245	0	0	_aPremalignant Conditions of the Oral Cavity _cedited by Peter A. Brennan, Tom Aldridge, Raghav C. Dwivedi
264		1	_aSingapore _bSpringer International Publishing _c2019
300			_a1 recurso en línea (XIV, 276 páginas) _b51 ilustraciones, 48 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aHead and Neck Cancer Clinics _x2364-4060
490	0		_aMedicine (Springer-11650)
505	0		_aIntroduction to oral premalignant lesions including epidemiology -- Development, relevant anatomy and physiology of the oral cavity and mucosa -- Basic cellular and molecular biology to include the effects of carcinogens (smoking, alcohol, betel nut, HPV, chronic candida) -- Pathophysiology of the transformation from normal mucosa to invasive malignancy (carcinogenesis) including dysplasia -- Leukoplakia including benign lesions -- Erythroplakia and erythroleukoplakia.-The lichenoid group of diseases including erosive and atrophic lichen planus.-Systemic diseases that are potentially pre-cancerous (iron deficiency anaemic, immunosuppression -- Clinical presentation of oral mucosal premalignant lesions (this will be a larger section), and include high and low risk lesions -- Diagnosis including biopsy techniques and other relevant investigations -- Management of premalignant disease of the oral mucosa with up to date clinical trials and adjuvant therapies. Role of surgery, laser treatments -- The future. .
520	3		_aOral squamous cell carcinoma (SCC) is the 13th commonest cancer worldwide, and the most common cancer in the Asian subcontinent due to the widespread habit of tobacco and betel nut chewing. Despite many advances in diagnosis and treatment, the survival statistics have only marginally improved. However our understanding of the disease process and transformation from pre-cancerous lesions of the oral mucosa to an invasive SCC cancer and their progression has expanded exponentially. There are many conditions of the oral mucosa that can progress to an invasive malignancy. A thorough understanding of these conditions is a prerequisite for all those involved in the management of the diseases of the oral mucosa and head and neck region. The recognition and timely treatment of potentially pre-malignant conditions of the oral cavity can minimize the change to an overt malignancy in many patients through patient education, appropriate treatment and surveillance. In this book we cover relevant anatomy, biology, diagnosis and latest management strategies for pre-cancerous conditions that affect the oral mucosa. The respective chapters are written by expert contributors from around the world, lending the book a global perspective and making it an essential guide for all those involved in the management of pre-malignant lesions arising in this challenging anatomical region.
988			_aSpringer_Medicine_2019
650		7	_aBoca _2embne _9229978 _xCáncer
700	1		_aBrennan, Peter A. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aAldridge, Tom. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aDwivedi, Raghav C. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9789811329302
776	0	8	_iPrinted edition: _z9789811329326
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-13-2931-9 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_dz _feng _ggw _h0 _b11/2021 _ea